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Abstract
Surface enhanced spatially offset Raman spectroscopy (SESORS) has the potential to
serve as a tool for non-invasive, early detection of a variety of disease states, especially
neurological disease. In this study, a great deal of preliminary work was completed in order to
achieve the SESORS detection of major neurochemicals and their mixtures in a brain tissue
mimic through bone. First, seven neurotransmitters were detected at physiological
concentrations using surface enhanced Raman spectroscopy (SERS), and their individual limits
of detection were established. Next, Teflon signal was collected through bone and brain tissue
mimic at depths of 18 mm using spatially offset Raman spectroscopy (SORS). Then, a low
concentration of serotonin was sensed in a mouse brain through the skull using SESORS. Finally,
methods were developed to selectively capture and detect dopamine molecules using SERS.
Introduction
Neurotransmitters serve as possible biomarkers for neurological diseases, which are
difficult to detect in their early stages when treatment would be most beneficial. The basic
functions, structures, and physiological concentrations of several important neurotransmitters
are shown in Table 1. For example, dopamine is linked to motor control and is involved in
Parkinson’s disease. The death of dopamine-producing neurons in the substantia nigra of
Parkinson’s patients results in loss of motor function (1), and the disease is typically not
diagnosed until symptoms have caused irreversible damage.
Recently, the need has been recognized for better methods to monitor neurochemicals
in vivo. Current methods, such as microdialysis (2) and cyclic voltammetry (3), are highly
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invasive and often involve removing portions of the skull to surgically implant the required
technology. Raman spectroscopy, in particular SERS, has garnered attention as a possible tool
for biosensing and disease diagnosis (4), yet in practice, SERS is also an invasive technique, since
it requires obtaining bodily fluids or tissue samples for analysis. SESORS is unique in that it can
provide highly selective, label free, and minimally invasive detection of low concentrations of
chemicals with rapid sample analysis. SESORS could lead to earlier detection of neurological
diseases and provide critical knowledge about their progression.

Table 1: Neurotransmitter structures, functions, and limits of detection (Adapted from Sharma
group).
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Background
Raman Spectroscopy
Raman spectroscopy is an inelastic light scattering technique that provides information
about the identity of a molecule based on its vibrational modes. For a vibration to be Raman
active, the molecule must undergo a change in polarizability when it is excited to a virtual state
with a monochromatic light source. When the molecule is excited, an induced dipole is created,
according to the equation 𝜇 = 𝛼𝐸, where 𝛼 is the polarizability and 𝐸 is the electric field. Each
Raman active molecule has a characteristic spectrum, or a “molecular fingerprint”. Raman
signal is highly specific, sensitive, non-destructive, and can be rapidly collected. On the other
hand, its major disadvantage is that it is inherently weak. Only one in every 107 incident
photons is Raman scattered (5), so certain techniques must be used to enhance the strength of
Raman signal, one of which is by increasing the electric field surrounding the molecule.
Surface Enhanced Raman Spectroscopy
Surface enhanced Raman spectroscopy (SERS) yields amplified Raman signal by taking
advantage of the electric field produced by the excitation of conduction electrons on the
surface of noble metal nanoparticles (6). This phenomenon is known as the localized surface
plasmon resonance (LSPR). When a molecule encounters this electric field, its Raman signal can
be enhanced by up to a factor of 108 (7). SERS enhancement allows for the identification and
quantification of very low concentrations of molecules.

5

Spatially Offset Raman Spectroscopy
Spatially offset Raman spectroscopy (SORS) enables the detection of Raman signal from
the subsurface layers of diffusely scattering media. Photons enter the deeper layers of a
sample, migrate laterally, and then exit the sample. To gather information from these
subsurface layers, signal is collected at a point that is offset from the location of the incident
light. Inverse SORS differs from conventional SORS in that it involves illuminating the sample in
a circle and collecting the scattered light from a point in the center of the circle (8). The radius
of the circle equals the degree of spatial offset. A larger offset permits incident photons to
penetrate deeper in the sample, and Raman signal can be obtained from further beneath the
surface of the sample. The combination of SERS and SORS gives surface enhanced spatially
offset Raman spectroscopy, or SESORS.
Experimental Methods
Nanoparticle Synthesis and Characterization
On a regular basis, gold nanoparticles (AuNPs) were synthesized using a citrate
reduction method based on the procedure reported by Frens (9). Due to its lack of toxicity, gold
is an excellent material for in vivo experimentation. Silver nanoparticles (AgNPs) were
occasionally synthesized as well using the protocol outlined by Lee and Meisel (10). After each
synthesis, the batch of nanoparticles was characterized using ultraviolet-visible extinction
spectroscopy to identify its localized surface plasmon (Figure 2), which is an indication of the
shape and size distribution of the particles. The LSPR of the gold colloids tended to be around
540 nm, while that of the silver colloids was usually about 420 nm. To test their SERS activity,
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100 µM benzenethiol- a common Raman reporter molecule was adsorbed onto the surface of
the colloids for SERS analysis. At such a low concentration, no normal Raman signal could be
obtained from the benzenethiol, but if the nanoparticles were SERS active, they enhanced the
Raman signal of the molecule to a measurable level (Figure 3). Additionally, the nanoparticles
were imaged using scanning electron microscopy (SEM) to better understand their structure
(Figure 4).

Figure 2: Localized surface plasmon resonance of AuNPs, with the maximum wavelength at 539
nm (Adapted from Sharma group).
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Figure 3: SERS spectrum of benzenethiol on AuNPs. ex=785 nm, P=5 mW, t=1 s (Adapted from
Sharma group).

100nm

200nm

Figure 4: SEM images of AuNPs (Adapted from Sharma group).

Instrumentation
The Sharma lab is equipped with homebuilt macro- and micro- Raman optical systems,
which allow the group to perform experiments using normal Raman, SERS, SORS, and SESORS.
The macro system (Figure 5) is equipped with a 785 nm continuous wave laser, and signal is
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collected in a 180° backscattering geometry. This system has the capability to achieve various
spatial offsets using axicon lenses so that inverse SORS signal can be collected from the sample.
The micro system (Figure 5) includes four laser sources with wavelengths of 488 nm, 532 nm,
633 nm, and 785 nm on the same beam path, and it incorporates a confocal microscope to
focus the laser light onto the sample before it is collected by the spectrometer. Only the 785
nm laser is represented in the figure below.

Figure 5: Sharma lab micro setup (top) and macro setup (bottom) (Adapted from Sharma
group).
9

Normal Raman and SERS Measurements of Seven Neurotransmitters
Dopamine, serotonin, melatonin, glutamate, GABA, epinephrine, and norepinephrine
were purchased in their solid forms, and their normal Raman spectra were acquired using
excitation wavelengths of 532 nm (Figure 6), 633 nm (Figure 7), and 785 nm (Figure 8). The solid
state data provided information about the major vibrations of each molecule. It also showed
that although the positions of the vibrations were consistent in each spectrum, certain
vibrations were more intense at different wavelengths. Since the intensity of Raman signal
increases at a rate inversely proportional to the fourth power of the excitation wavelength
(𝜆

1

𝑒𝑥

4

), the strongest signal was observed at 532 nm. The spectra of GABA and glutamate

displayed much weaker Raman signal than the other neurotransmitters because they have
linear structures and lack rings containing conjugated pi bonds. These spectra were used as a
basis for understanding the Raman bands that would be expected from the neurotransmitters
when incorporated into solution.
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Figure 6: Spectra of solid neurotransmitters at 𝜆𝑒𝑥 = 532 nm, P=10 mW, t=30 s (11).

Figure 7: Spectra of solid neurotransmitters at 𝜆𝑒𝑥 = 633 nm, P=10 mW, t=30 s (11).
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Figure 8: Spectra of solid neurotransmitters at 𝜆𝑒𝑥 = 785 nm, P=10 mW, t=30 s (11).

Next, a series of SERS spectra were collected for the seven neurochemicals. In order to
maximize the intensity of the SERS signal, the optimum experimental conditions were
determined. For instance, the centrifuging speeds and durations for both the gold and silver
particles were optimized to remove the maximum number of particles from the supernatant.
The best centrifuging conditions were 4200 rpm for 15 minutes for gold and 5000 rpm for five
minutes, a total of two times, for silver.
Additional optimization included adjusting the amount of time that the analyte was
allowed to incubate with the nanoparticles before the SERS measurements were taken, along
with changing the pH of the nanoparticle solution. The neurotransmitter solutions gave the
strongest SERS signal after an hour of incubation and at a pH of 3. Decreasing the pH of the
nanoparticles effectively protonated their negatively charged surfaces, which allowed the
neurotransmitters to more favorably adsorb onto the colloids. The negatively charged citrate
12

molecules remaining on the nanoparticle surface create the repulsive forces that keep the
nanoparticles dispersed in solution. At a pH below 3, the nanoparticles become unstable and
quickly aggregate and fall out of solution.
Various concentrations (between 1 nM and 500 µM) of the neurotransmitter of interest
were adsorbed onto gold nanoparticles with a pH of 3, and SERS signal was obtained at 633 nm
and 785 nm excitation wavelengths. The same concentrations of neurotransmitters were
adsorbed onto silver nanoparticles as well, and the solutions were excited at wavelengths of
532 nm, 633 nm, and 785 nm to obtain SERS signal. Figure 9 shows the SERS spectra at 785 nm
of four concentrations of melatonin and exemplifies the proportional relationship between
analyte concentration and SERS intensity in this range.

Figure 9: SERS of melatonin on AuNPs. ex=785 nm, P=5 mW, t=60 s (12).
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Shown below are the spectra at two excitation wavelengths for 50 µM concentrations of
each of the seven neurochemicals on gold colloids (Figures 10 and 11). Each molecule exhibits a
distinct Raman spectrum, which demonstrates the chemical specificity of the approach.

Figure 10: SERS of 50 µM neurotransmitter solutions on AuNPs. ex=633 nm, P=3 mW, t=60 s
(11).

Figure 11: SERS of 50 µM neurotransmitter solutions on AuNPs. ex=785 nm, P=5 mW, t=60 s
(11).
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Given that the amount of data collected during this study was quite large, spectral
differences were difficult to discern by eye. Therefore, principle component analysis (PCA) was
used to analyze the spectra, distinguish differences between them, and determine limits of
detection. PCA is a multivariate mathematical technique that reduces the number of variables
in a data set into principal components, which are represented by loadings that serve as
reference spectra to which the software compares each sample. In PCA, the first principal
component has the largest variance, which means it represents the source of the largest
variability in the data. Each successive principle component represents the next highest source
of variance. When the principle components are graphed, samples with similar scores cluster,
meaning that they are highly similar. In this experiment, the limit of detection of a molecule
was defined as the spectrum of lowest concentration that was discernably different from, or
not clustered with, the other spectra. Two representative PCA graphs, along with the loadings
for their principle components, are shown here (Figures 12 and 13), and the various clusters of
neurotransmitters have been circled. The limits of detection of each neurotransmitter using
each type of nanoparticle and each excitation wavelength are compiled into Figure 14.
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Figure 12: PCA of neurotransmitters (1 nM to 500 µM) on AgNPs at 532 nm (11).

Figure 13: PCA of neurotransmitters (800 nM to 1 nM) on AuNPs at 633 nm (11).
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Neurotransmitter

AgNPs @
532 nm

AgNPs @
633 nm

AgNPs @
785 nm

AuNPs @
633 nm

AuNPs @
785 nm

Physiological
Concentration

Melatonin

50 μM

50 μM

200 nM

100 nM

100 nM

100 nM

Serotonin

200 nM

100 nM

200 nM

100 nM

100 nM

1 μM

Glutamate

50 μM

600 nM

10 μM

--

--

1 μM

Dopamine

10 μM

10 μM

10 μM

100 nM

100 nM

1 μM

GABA

500 μM

100 nM

200 nM

--

--

1 mM

Norepinephrine

10 μM

10 μM

10 μM

100 nM

200 nM

3 μM

Epinephrine

10 μM

10 μM

500 μM

10 μM

10 μM

1 mM

Figure 14: Limits of detection of neurotransmitters using SERS (11).

SERS Measurements of Neurotransmitter Mixtures
Since neurochemicals rarely exist naturally in isolation, SERS experiments were also
performed in more complex environments using mixtures of neurotransmitters. First, a mixture
was prepared using 50 μM concentrations of all seven neurotransmitters in water. A second
aqueous mixture was made using concentrations of the seven neurotransmitters based on the
quantities typically found in the human brain. The SERS spectra of these mixtures on gold
nanoparticles at 785 nm are shown in Figure 15. Individual characteristic peaks of the majority
of the neurotransmitters can be seen and are labeled in this figure. The same peaks appear in
both mixtures, although they exhibit different intensities when the proportions of the
neurotransmitters in the mixture are changed.
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Figure 15: SERS of mixtures of neurotransmitters on AuNPs. ex=785 nm, P=5 mW, t=60 s
(Adapted from Sharma group).
SORS Depth Study
Next it was shown that the inverse SORS detection of Teflon- another common Raman
reporter- could be achieved through a 1 mm piece of bone and up to 18 mm of agarose gel,
which serves as a brain tissue mimic. Square pieces of agarose gel were prepared, each with a
thickness of 2 mm. A flat portion of a rat skull was placed in front of a piece of Teflon, and a 785
nm laser was focused onto the bone. A Raman spectrum was collected in this position, termed
the 0 mm offset, before an axicon was placed in the laser line to create a 4 mm annular beam
on the bone, achieving a 2 mm offset. Slices of the brain tissue mimic were placed in 2 mm
increments between the bone and the Teflon, and the SORS measurements were repeated at
both offsets until no Teflon signal could be seen using the 2 mm offset. For each depth, a scaled
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subtraction was performed. The 0 mm offset spectrum was subtracted from the 2 mm offset
spectrum to remove the contribution of the bone and make the Teflon signal more easily
visible. As can be seen in Figure 16, the Teflon peak at 734 cm-1 persisted until the agarose gel
thickness reached 20 mm. This study demonstrated the viability of inverse SORS as a method
for obtaining Raman signal from the human brain through the skull, which is only 3 mm thick at
the substantia nigra.
734

Figure 16: SORS of Teflon through bone and increasingly greater depths of agarose gel. ex=785
nm, P=90 mW, t=60 s.
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SESORS of Neurotransmitters in a Brain Tissue Mimic through the Skull
Because Raman signal is weak, it would be difficult to obtain neurochemical information
using SORS alone; it was important to show that a spatial offset could be combined with surface
enhancement to achieve the SESORS detection of low concentrations of neurotransmitters in a
brain tissue mimic through bone. Pieces of agarose gel were incubated with 100 μM
neurotransmitter solutions for one hour to mimic brain slices with neurochemicals present.
Then, gold nanoparticle solutions with a pH of 3 were added to the gels and allowed to
incubate for another hour. The samples were placed onto the sample holder of the macro
system and the SESORS signal of each was acquired at 785 nm through the piece of rat skull
mentioned earlier. Before collecting the final data, experimental parameters such as the time
the analyte was allowed to incubate on the gel and the degree of spatial offset were optimized
to achieve maximum SESORS signal. A 2 mm offset provided the strongest signal. The
procedure was repeated with mixtures of neurotransmitters, such as melatonin mixed with
dopamine, serotonin mixed with dopamine, and serotonin mixed with melatonin.
The data was processed by subtracting the 0 mm offset from the 2 mm offset to remove
the majority of the bone signal at 960 cm-1. For a few of the samples, figures were compiled
showing the 0 mm offset spectrum, the 2 mm offset spectrum, the subtracted spectrum, and
the spectrum of the gel alone (Figures 17 – 20). Characteristic peaks from the
neurotransmitters were observed in all of the spectra, including the spectra of the mixtures.
Overall, by using a 2 mm offset- versus a 0 mm offset- more signal was obtained through bone
from the neurotransmitter or neurotransmitters of interest. The ratio of analyte signal to bone
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signal increased as the offset increased. In other words, by employing a greater offset, more
scattered light was being collected from the brain tissue mimic beneath the bone.

Serotonin

Figure 17: SESORS data for serotonin in agarose gel through bone. ex=785 nm, P=90 mW,
t=120 s (12).
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Figure 18: SESORS data for dopamine in agarose gel through bone. ex=785 nm, P=90 mW,
t=120 s (12).

Melatonin

Figure 19: SESORS data for melatonin in agarose gel through bone. ex=785 nm, P=90 mW,
t=120 s (12).
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Figure 20: SESORS data for a serotonin and dopamine mixture in agarose gel through bone.
ex=785 nm, P=90 mW, t=120 s.

SESORS Detection of Serotonin in vivo (Mouse Model)
A sacrificed mouse was obtained from the Sparer group at the University of Tennessee.
The head was shaved, and a SORS spectrum was acquired through the skull using a 785 nm
laser at a 0 mm offset (Figure 21). Since bone is partially transparent at this wavelength and the
mouse skull is very thin, some subsurface information was gathered even at a 0 mm offset. The
observed peaks corresponded to bone and decomposing tissue in the brain. The skull was
opened, and 100 µM serotonin and gold nanoparticles were injected into the brain. The bone
was measured to be about 0.5 mm to 0.8 mm thick, suggesting that a 1 mm offset would allow
chemical information to be retrieved from the brain. The skull was replaced, and another
spectrum was acquired with no offset (Figure 21). Finally, a SESORS spectrum was collected at a
23

1 mm offset. The final two spectra exhibit peaks at 820 cm-1, 1221 cm-1, 1341 cm-1, and 1522
cm-1, which are characteristic of serotonin (Figure 21), meaning that this technique has the
ability to detect neurotransmitters in vivo through the skull.

Figure 21: Initial SORS spectrum of the mouse brain through the skull (top, blue). SESORS
spectrum (with initial SORS spectrum subtracted) of the mouse brain through the skull after a
100 µM serotonin injection at 0 mm offset (red, middle) and at 1 mm offset (green, bottom).
ex=785 nm, P=90 mW, t=120 s (13).

Selective Detection of Dopamine using Boronic Acid
Selectively targeting molecules of interest would allow for better SESORS detection of
neurochemicals in the brain. In order to selectively capture and detect dopamine molecules in a
brain tissue mimic, boronic acids were employed as capture ligands. A 100 µM solution of 4mercaptophenylboronic acid (4-MPBA) was prepared in PBS. The sulfur groups of the acid
molecules were bound to the surface of gold nanoparticles, leaving the diol groups available to
24

target the diol groups of dopamine. Various concentrations of dopamine were added to the
boronic acid-conjugated gold nanoparticles (BA-AuNPs) and were allowed to incubate for one
hour. Then, the solutions were added to pieces of agarose gel, and SERS spectra were collected
24 hours later. The SERS data collected after the full day incubation period is displayed below
(Figure 22). The bands at 1006 cm-1, 1258 cm-1, 1344 cm-1, and 1448 cm-1 correspond to
dopamine, while the other peaks represent the contribution from the remaining boronic acid
molecules and gold nanoparticles in the gel. These peaks correlate well with those observed by
Yu et al. in their SERS data of dopamine on silver nanoparticle dimers (14). This data suggests
that boronic acid-functionalized gold nanoparticles are a viable option for achieving the
selective SERS detection of dopamine.

Figure 22: SERS detection of dopamine in agarose gel using BA-AuNPs.
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Conclusions and Future Work
The series of experiments outlined in this work represent the groundwork for using
SESORS for the in vivo diagnosis of neurological disease. First, gold and silver nanoparticles
were successfully synthesized and were used to detect low concentration of various
neurotransmitters at multiple excitation wavelengths using SERS. With the help of PCA, the
limits of detection of our method were established for seven neurotransmitters under various
experimental conditions. Individual neurotransmitters were detected within physiologically
representative mixtures. Serotonin, dopamine, melatonin, epinephrine, and norepinephrine
were identified at concentrations of 100 µM in a brain tissue mimic through a rat skull using
SESORS. Then, mixtures of serotonin, dopamine, and melatonin were detected using the same
methodology. After 24 hours of incubation, dopamine was captured using boronic acidconjugated nanoparticles, and signal was obtained using SERS.
There remains a significant amount of work to be done in the future to develop a
SESORS technique to be used in the clinical setting. For instance, the brain contains numerous
biomolecules, so steps should be taken to improve the selective detection of the
neurotransmitters of interest. The selectivity of the BA-AuNPs described above should be
tested on dopamine in the presence of other neurotransmitters and other biological molecules.
The BA-AuNPs should be incorporated into SESORS experiments to detect dopamine signal
through bone, and they should be used to sense dopamine in the brain of an animal model.
Eventually, this technology is likely to be tailored for use in patient care, as SESORS shows great
promise as a diagnostic tool. In conclusion, this work represents the first steps in developing a
minimally invasive method for the early detection of neurological disease.
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